Health Alert:

Coronavirus Information: Vaccinations | Testing | Safety Policies & Visitor Guidelines | Appointments & Scheduling | FAQs

Covid Calls

Vaccine Scheduling Update: Currently, our vaccine supply is very small, and we are unable to accept phone calls to schedule vaccine appointments. Please check back here for updates.

Leading the Mission to Prevent and Reverse Blindness

Worldwide, 285 million people are visually impaired and 39 million are blind. Penn Ophthalmology is a preeminent medical research center at the forefront of preventing and reversing visual impairment and blindness. In 2017, Penn Ophthalmology pioneered the first gene therapy for a hereditary retinal disease to be approved by the FDA. This therapy has allowed patients born with blinding conditions to regain and maintain vision. Researchers at Penn are currently developing therapies for a range of other blinding disorders. Many of the Department's advances in vision-saving therapy have been made possible by donations from individuals and organizations.

Specific Funds

Gifts can be made to specific funds through the following links:

Gifts by Check

Gifts by check, made payable to the Scheie Eye Institute, can be mailed to:

Penn Medicine Development & Alumni Relations
Attn: Mary Tong
3535 Market Street, Suite 750
Philadelphia, PA 19104

To learn more, contact Mary Tong at 215-746-2204 or

Share This Page: